entertainment -WSS

entertainment

author：fashion 2025-09-27 12:22:03 - browse：49837

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Doctor of U.S. President Joe Biden says he is fit for duty

hotspot

WSS

Flu vaccine offering decent levels of protection this winter, new data show

Elisabeth Bik tackles the widespread issue of research misconduct

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Redefining sustainability for the pharmaceutical industry

How to fix the rural physician shortage in the U.S.

Wikipedia

entertainment

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

STAT Madness 2024: Meet the contenders

Psychedelics group wrestles with new pharma identity

FogPharma raises $145 million in rare Series E round

Medicare proposal to cover medical devices draws a mixed reaction

Kenai launches with $82 million for Parkinson’s stem cell therapy

Anesthesiologist group: stop taking Ozempic before surgery

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Medical records are filled with copy

Cholera vaccine supplies dangerously low, outbreaks surging

explore

Laying a path for careers in science

Study fuels hope CAR

Flu vaccine offering decent levels of protection this winter, new data show

Laying a path for careers in science

ALS groups 'won't be played again' by the FDA, drug sponsors

Redefining sustainability for the pharmaceutical industry

hotspot

knowledge

focus

entertainment